Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
9 mg/mL (Need ultrasonic or warming)
Treatment with Anacetrapib leads to significant increases in HDL-C levels at day 0
153436-54-5
CFI-402257 also demonstrates antitumor activity in a platinum-resistant PDX model of high-grade serous ovarian cancer (6
and size in BALB/c mice
GW-627368X - CAS# 439288-66-1 ry of Histone Demethylase 9 mg/mL (Need ultrasonic orGW 627368X, CAS No. 439288 66 1, is a novel, potent and selective competitive antagonist of prostanoid EP4 receptors with additional human TP receptor affinity. Oral administration of GW627368X showed significant tumor regression characterized by tumor reduction and induction of apoptosis. Reduction in prostaglandin E2 synthesis also led to reduced level of VEGF in plasma. GW627368X will be a valuable tool to explore the role of the prostanoid EP4
US$ 100.25
US$ 68.00
US$ 154.97
US$ 109.95
US$ 16.00
US$ 60.00
US$ 255.25
US$ 74.50
US$ 144.97
US$ 176.50
US$ 160.50
US$ 149.00
US$ 252.47
US$ 68.00